Dupilumab Treatment For Up To 3 Years Demonstrates Sustained Efficacy In Adult Patients With Moderate To Severe Atopic Dermatitis: Results From Liberty Ad Adult Ole
Journal of The American Academy of Dermatology(2020)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要